Understand the source comparison
Best Cerebrolysin Dosage for TBI Support: Research Protocol Comparison
Acute Neuroprotection (0–72h post-injury) 30–50ml daily 10–21 days Slow IV infusion in 100–250ml saline over 30–60 minutes BDNF/NGF receptor activation blocks apoptotic cascade and excitotoxic damage Moderate-to-severe TBI with Glasgow Coma Scale 3–12; initiat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Acute Neuroprotection (0–72h post-injury)
- 30–50ml daily
- 10–21 days
- Slow IV infusion in 100–250ml saline over 30–60 minutes
- BDNF/NGF receptor activation blocks apoptotic cascade and excitotoxic damage
- Moderate-to-severe TBI with Glasgow Coma Scale 3–12; initiated in ICU setting within first 72 hours
- Subacute Recovery (4–30 days)
- 10–30ml daily
- 20–30 days
- Slow IV infusion in saline
- Supports axonal sprouting, dendritic branching, synaptogenesis in perilesional tissue
- Post-stabilization phase; used alongside physical/cognitive rehabilitation
- Chronic Neuroplasticity Support (>3 months)
- 10–20ml daily
- 10–14 days per cycle, repeated every 8–12 weeks
- Enhances compensatory network reorganization and synaptic remodeling
- Long-term functional recovery; addresses persistent cognitive or motor deficits
- Pediatric TBI (weight-adjusted)
- 0.5–1.0ml/kg daily (max 30ml)
- Slow IV infusion in weight-appropriate saline volume
- Same neurotrophic mechanisms as adult protocols but scaled to body weight and developing CNS
- Used in pediatric ICU for moderate-to-severe TBI in children >2 years old